Prospective study of acute HIV-1 infection in adults in East Africa and Thailand

New England Journal of Medicine

Volumn 374, Issue 22, 2016, Pages 2120-2130

  Robb, Merlin L ^a,b   Eller, Leigh A ^a,b   Kibuuka, Hannah ^e   Rono, Kathleen ^f   Maganga, Lucas ^g   Nitayaphan, Sorachai ^h   Kroon, Eugene ^h,i   Sawe, Fred K ^f   Sinei, Samuel ^f   Sriplienchan, Somchai ^h   Jagodzinski, Linda L ^a   Malia, Jennifer ^a   Manak, Mark ^a,b   De Souza, Mark S ^h,i   Tovanabutra, Sodsai ^a,b   Sanders Buell, Eric ^a,b   Rolland, Morgane ^a,b   Dorsey Spitz, Julie ^a,b   Eller, Michael A ^a,b   Milazzo, Mark ^b   Li, Qun ^a,b   Lewandowski, Andrew ^c,d   Wu, Hao ^a   Swann, Edith ^b   O'Connell, Robert J ^h   Peel, Sheila ^a   Dawson, Peter ^c,d   Kim, Jerome H ^a,j   Michael, Nelson L ^a   more..

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Walter Reed Project ^*  (United States)

^d EMMES   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f Walter Reed Project   (Kenya)

^g Mbeya Medical Research Centre   (Tanzania)

^h ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

ⁱ THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^j International Vaccine Institute   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; VIRUS ANTIBODY;

ADULT; AFRICA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HETEROSEXUAL FEMALE; HIGH RISK PATIENT; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIMIT OF QUANTITATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALE TO FEMALE TRANSGENDER; NATURAL KILLER CELL; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; THAILAND; VIRUS LOAD; ADOLESCENT; BLOOD; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; VIREMIA; VIROLOGY;

ADOLESCENT; ADULT; AFRICA, EASTERN; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; THAILAND; VIRAL LOAD; VIREMIA;

EID: 84973401278     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1508952     Document Type: Article

References (39)

1. Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acquir Immune Defic Syndr 2007; 45: 445-8.
2. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 2006; 42: 1333-9.
3. Lefrère JJ, Roudot-Thoraval F, Mariotti M, et al. The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. J Infect Dis 1998; 177: 1541-8.
4. Lindbäck S, Karlsson AC, Mittler J, et al. Viral dynamics in primary HIV-1 infection. AIDS 2000; 14: 2283-91.
5. Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195: 951-9.
6. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004; 189: 1785-92.
7. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191: 1403-9.
8. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
9. Cohen MS, Dye C, Fraser C, Miller WC, Powers KA, Williams BG. HIV treatment as prevention: debate and commentary - will early infection compromise treatment-as-prevention strategies? PLoS Med 2012; 9(7): e1001232.
10. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011; 378: 256-68.
11. Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999; 5: 512-7.
12. Ananworanich J, Schuetz A, Vandergeeten C, et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One 2012; 7(3): e33948.
13. Jain V, Hartogensis W, Bacchetti P, et al. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis 2013; 208: 1202-11.
14. Sáez-Cirión A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated anti-retroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013; 9(3): e1003211.
15. Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Anti-retroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet 2013; 382: 1515-24.
16. Hill AL, Rosenbloom DI, Fu F, Nowak MA, Siliciano RF. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1. Proc Natl Acad Sci U S A 2014; 111: 13475-80.
17. Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125: 257-64.
18. Gay C, Dibben O, Anderson JA, et al. Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 2011; 6(5): e19617.
19. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 16: 1119-29.
20. Pilcher CD, Joaki G, Hoffman IF, et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007; 21: 1723-30.
21. Sullivan PS, Fideli U, Wall KM, et al. Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS 2012; 26: 175-84.
22. Ananworanich J, Fletcher JL, Pinyakorn S, et al. A novel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology 2013; 10: 56.
23. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-9.
24. Henrard DR, Daar E, Farzadegan H, et al. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 305-10.
25. Kaufmann GR, Cunningham P, Kelleher AD, et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. J Infect Dis 1998; 178: 1812-5.
26. Kaufmann GR, Cunningham P, Zaunders J, et al. Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. J Acquir Immune Defic Syndr 1999; 22: 437-44.
27. Novitsky V, Woldegabriel E, Kebaabetswe L, et al. Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. J Acquir Immune Defic Syndr 2009; 50: 65-76.
28. Richardson BA, Mbori-Ngacha D, Lavreys L, et al. Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection. J Virol 2003; 77: 7120-3.
29. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344: 720-5.
30. Ndhlovu ZM, Kamya P, Mewalal N, et al. Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point. Immunity 2015; 43: 591-604.
31. Dykhuizen M, Mitchen JL, Montefiori DC, et al. Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression. J Gen Virol 1998; 79: 2461-7.
32. Kuhrt D, Faith SA, Leone A, et al. Evidence of early B-cell dysregulation in simian immunodeficiency virus infection: rapid depletion of naïve and memory B-cell subsets with delayed reconstitution of the naïve B-cell population. J Virol 2010; 84: 2466-76.
33. Mattapallil JJ, Letvin NL, Roederer M. T-cell dynamics during acute SIV infection. AIDS 2004; 18: 13-23.
34. Levesque MC, Moody MA, Hwang KK, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med 2009; 6(7): e1000107.
35. Bebell LM, Pilcher CD, Dorsey G, et al. Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS 2010; 24: 1945-52.
36. Sanders EJ, Mugo P, Prins HA, et al. Acute HIV-1 infection is as common as malaria in young febrile adults seeking care in coastal Kenya. AIDS 2014; 28: 1357-63.
37. Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One 2012; 7(11): e50522.
38. Hollingsworth TD, Pilcher CD, Hecht FM, Deeks SG, Fraser C. High transmis-sibility during early HIV infection among men who have sex with men - San Francisco, California. J Infect Dis 2015; 211: 1757-60.
39. Parrish NF, Gao F, Li H, et al. Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 2013; 110: 6626-33.